| abstract |
The present invention addresses the problem of providing a novel therapeutic drug for mental illness with abnormal neurodevelopment. Provided is an antipsychotic containing a Rho kinase inhibitor as an active ingredient. The antipsychotic can be utilized, for example, in the treatment of schizophrenia, autism spectrum disorders, bipolar disorder, or depression. |